FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry, specifically to a novel heterocyclic compound of general formula (II) or to a pharmaceutically acceptable salt, where each R9 is -H; each R10 is independently -H, -OH, NH(methyl), -N(methyl)(methyl) or -O-methyl; each of Q1, Q2 and Q3 is independently CR10 or N; X is CHR10 or O; and each m is 1. The invention also relates to a pharmaceutical composition based on a compound of formula (II), a treatment method based on the use of a compound of formula (II), and a method of determining the level of activity of P2Y13 in a subject, based on the use of a compound of formula (II).
EFFECT: obtaining novel compounds having agonistic activity with respect to the P2Y13 receptor.
18 cl, 28 dwg, 4 tbl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
(ALPHA-SUBSTITUTED ARALKYLAMINO- AND HETEROARYLALKYLAMINO)PYRIMIDINYL- AND 1,3,5-TRIAZINYLBENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF AND USE THEREOF IN TREATING PROLIFERATIVE DISEASES | 2012 |
|
RU2608742C2 |
PYRROLE DERIVATIVES AS MEDICINAL SUBSTANCES | 2005 |
|
RU2470916C2 |
N1-(4-(5-(CYCLOPROPYLMETHYL)-1-METHYL-1H-PYRAZOLE-4-YL)PYRIDINE-2-YL)CYCLOHEXANE-1,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF CK1 AND/OR IRAK1 FOR THE TREATMENT OF CANCER | 2018 |
|
RU2761457C2 |
SPIRO(5,5)UNDECANE DERIVATIVES | 2009 |
|
RU2515895C2 |
CONTAINING A SUBSTITUTE, WHICH IS BUTANE, IN THE HETEROCYCLIC RING A PYRIDONE DERIVATIVE FOR TREATING FIBROSIS AND INFLAMMATORY DISEASES | 2017 |
|
RU2738844C2 |
D-AMINO ACID OXIDASE INHIBITORS AND THEIR THERAPEUTIC USE | 2018 |
|
RU2795513C2 |
PYRROLO[2,3-b]PYRIDINE DERIVATIVES INHIBITING ACTIVITY OF ANTI-APOPTOTIC Bcl-2 PROTEINS | 2011 |
|
RU2567857C2 |
APOPTOSIS-INDUCING AGENTS FOR TREATING CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2010 |
|
RU2539587C2 |
THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2015 |
|
RU2733405C2 |
HYDROXYMETHYL CYCLOHEXYLAMINES | 2009 |
|
RU2514192C2 |
Authors
Dates
2016-03-10—Published
2011-10-18—Filed